Drugs Online » Prescription Drugs 17 » Zarontin Syrup Generic Ethosuximide
IndicationsZARONTIN is indicated for the control of petit mal epilepsy.This medication is used alone or with other medications to control certain types of seizure problems (e.g. absence or petit mal seizures). Controlling seizures helps to prevent injury from falling and allows you to lead a more normal life. Ethosuximide belongs to a class of drugs known as anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.Dosage and AdministrationZARONTIN is administered orally.Recommended initial daily dose for children and adults is approximately 20-30 mg/kg administered in two divided doses. This regimen will frequently achieve plasma levels in the therapeutic range of 40-100 mg/L. (Optimum 75 mg/L). As the dose serum level relationship may be curvilinear in individual patients dosage should be increased by small increments.One useful method is to increase the daily dose by 250 mg every four to seven days until control is achieved with minimal side effects. Dosages exceeding 1.5 g daily in divided doses should be administered only under the strictest supervision of the physician. Plasma level monitoring is recommended. ZARONTIN may be administered in combination with other anticonvulsants when other forms of epilepsy coexist with petit mal.
Buy Zarontin Syrup Generic Ethosuximide and other Prescription Drugs 17 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Zarontin Syrup Generic Ethosuximide:
Product Type: Prescription Drugs 17
Zarontin Syrup ( Generic Ethosuximide )
Zarontin Syrup (Generic Ethosuximide)
Generic Ethosuximide
250mg
Generic Ethosuximide Zarontin Syrup

View more
Prescription Drugs 17
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|